Tandem Diabetes Care Inc. (NASDAQ: TNDM) closed the day trading at $41.74 down -2.25% from the previous closing price of $42.70. In other words, the price has decreased by -$0.96 from its previous closing price. On the day, 663430 shares were traded. TNDM stock price reached its highest trading level at $43.12 during the session, while it also had its lowest trading level at $41.54.
For a better understanding of TNDM, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 4.25 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 85.95. For the most recent quarter (mrq), Quick Ratio is recorded 4.20 and its Current Ratio is at 4.80. In the meantime, Its Debt-to-Equity ratio is 0.67 whereas as Long-Term Debt/Eq ratio is at 0.67.
Upgrades & Downgrades
On October 18, 2022, Barclays started tracking the stock assigning a Overweight rating and target price of $75.
On October 12, 2022, Jefferies started tracking the stock assigning a Buy rating and target price of $75.Jefferies initiated its Buy rating on October 12, 2022, with a $75 target price.
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 16 when BERGER DAVID B sold 10,000 shares for $40.25 per share. The transaction valued at 402,500 led to the insider holds 3,029 shares of the business.
BERGER DAVID B sold 15,000 shares of TNDM for $604,800 on Dec 15. The EVP & Chief Operating Officer now owns 3,029 shares after completing the transaction at $40.32 per share. On Jun 08, another insider, BERGER DAVID B, who serves as the EVP & Chief Operating Officer of the company, sold 10,097 shares for $65.02 each. As a result, the insider received 656,515 and left with 2,457 shares of the company.
For the stock, the TTM Price-to-Sale (P/S) ratio is 3.27 while its Price-to-Book (P/B) ratio in mrq is 6.35.
Stock Price History:
Over the past 52 weeks, TNDM has reached a high of $125.54, while it has fallen to a 52-week low of $33.51. The 50-Day Moving Average of the stock is 41.63, while the 200-Day Moving Average is calculated to be 58.87.
Over the past 3-months, TNDM traded about 1.20M shares per day on average, while over the past 10 days, TNDM traded about 1.23M shares per day. A total of 64.24M shares are outstanding, with a floating share count of 62.97M. Shares short for TNDM as of Oct 13, 2022 were 5.59M with a Short Ratio of 5.32M, compared to 4.52M on Sep 14, 2022. Therefore, it implies a Short% of Shares Outstanding of 8.70% and a Short% of Float of 9.73%.
Current recommendations for the stock of the company come from 13 analysts. On average, analysts expect EPS of -$0.05 for the current quarter, with a high estimate of $0.06 and a low estimate of -$0.18, while EPS last year was $0.09. The consensus estimate for the next quarter is $0.24, with high estimates of $0.4 and low estimates of $0.1.
Analysts are recommending an EPS of between -$0.13 and -$0.45 for the fiscal current year, implying an average EPS of -$0.27. EPS for the following year is $0.39, with 13 analysts recommending between $0.91 and -$0.01.
A total of 14 analysts have provided revenue estimates for TNDM’s current fiscal year. The highest revenue estimate was $847.4M, while the lowest revenue estimate was $819.83M, resulting in an average revenue estimate of $836.4M. In the same quarter a year ago, actual revenue was $702.8M, up 19.00% from the average estimate. Based on 13 analysts’ estimates, the company’s revenue will be $981.18M in the next fiscal year. The high estimate is $1.03B and the low estimate is $925.7M. The average revenue growth estimate for next year is up 17.30% from the average revenue estimate for this year.